Effect of heme arginate administration on blood pressure in spontaneously hypertensive rats

Journal of Clinical Investigation

Volumn 86, Issue 1, 1990, Pages 213-219

  Levere, Richard D ^a   Martasek, Pavel ^a   Escalante, Bruno ^a   Schwartzman, Michel L ^a   Abraham, Nader G ^a  

^a NEW YORK MEDICAL COLLEGE   (United States)

Author keywords

Arachidonic acid; Cytochrome P 450; Eicosanoids; Heme oxygenase; Spontaneously hypertensive rat hypertension

Indexed keywords

ARACHIDONIC ACID; CYTOCHROME P450; HEME ARGINATE; HEME OXYGENASE;

ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; ESSENTIAL HYPERTENSION; INTRAPERITONEAL DRUG ADMINISTRATION; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMAL; ARACHIDONIC ACID; ARACHIDONIC ACIDS; ARGININE; BLOOD PRESSURE; BLOTTING, NORTHERN; CYTOCHROME P-450 ENZYME SYSTEM; GENE EXPRESSION; HEME; HEME OXYGENASE (DECYCLIZING); HEMIN; HYPERTENSION; KIDNEY; LIVER; MIXED FUNCTION OXYGENASES; RATS; RATS, INBRED SHR; RATS, INBRED STRAINS; RATS, INBRED WKY; RNA, MESSENGER; SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.;

EID: 0025332748     PISSN: 00219738     EISSN: None     Source Type: Journal    
DOI: 10.1172/JCI114686     Document Type: Article

References (32)

1. Bissell, D. M. 1988. Disorders of porphyrins or metals. In Cecil Textbook of Medicine, Volume 1. J. B. Wyngaarden and L. H. Smith, editors. W. B. Saunders Co., Philadelphia. 1182-1187.
2. Tenhunen, R. 1987. Heme arginate: its characterization, metabolism and clinical implications. In New Therapeutic Approach to Hepatic Porphyrias. P. Mustajoki, editor. Vammalan Kirjapaino Oy, Helsinki. 36-43.
3. Mustajoki, P., R. Tenhunen, O. Tokola, and G. Gothoni. 1986. Haem arginate in the treatment of acute hepatic porphyrias. Br. Med. J. 293:538-539.
4. Abraham, N. G., M. L. Friedland, and R. D. Levere. 1983. Heme metabolism in erythroid and hepatic cells. Prog. Hematol. 13:75-130.
5. Kordac, V., and P. Martasek. 1986. Haem arginate in acute hepatic porphyrias. Br Med. J. 293:1098.
6. Nordmann, Y., J. C. Deybach, J. F. Devars du Marne, and M. Cerf. 1987. Treatment of acute hepatic porphyrias with heme: a comparison of heme arginate and conventional heme therapy. In New Therapeutic Approach to Hepatic Porphyrias. P. Mustajoki, editor. Vammalan Kirjapaino Oy, Helsinki. 56-59.
7. Kordac, V., M. Kozakova, and P. Martasek. 1989. Changes of myocardial functions in acute hepatic porphyrias: role of heme arginate administration. Ann. Med. 21:273-276.
8. Okamoto, K., and K. Aoki. 1963. Development of a strain of spontaneously hypertensive rats. Jpn. Circ. J. 27:282-293.
9. Kawabe, K., T. X. Watanabe, K. Shiono, and H. Sokabe. 1978. Influence of blood pressure of renal isografts between spontaneously hypertensive and normotensive rats, utilizing the F1 hybrids. Jpn. Heart J. 19:886-894.
10. Beierwaltes, W. H., W. J. Arendshorst, and P. J. Klemmer. 1982. Electrolyte and water balance in young spontaneously hypertensive rats. Hypertension. 4:908-915.
11. Diley, J. R., C. T. Stier, and W. J. Arendshorst. 1984. Abnormalities in glomerular function in rats developing spontaneous hypertension. Am. J. Physiol. 246:F12-F20.
12. Merrick, B. A., M. H. Davis, D. E. Cook, T. L. Holeslaw, and K. Craig Schnell. 1985. Alterations in hepatic microsomal drug metabolism and cytochrome P450 proteins in spontaneously hypertensive rats. Pharmacology (Basel). 30:129-135.
13. Sacerdoti, D., N. G. Abraham, J. McGiff, and M. L. Schwartzman. 1988. Renal cytochrome P450-dependent metabolism of arachidonic acid in spontaneously hypertensive rats. Biochem. Pharmacol. 37:521-527.
14. Kappas, A., and G. S. Drummond. 1986. Control of heme metabolism with synthetic metalloporphyrins. J. Clin. Invest. 77:335-339.
15. Simionatto, C. S., K. E. Anderson, G. S. Drummond, and A. Kappas. 1985. Studies on the mechanism of Sn-protoporphyrin suppression of hyperbilirubinemia: inhibition of heme oxidation and bilirubin production. J. Clin. Invest. 75:513-521.
16. Sacerdoti, D., B. Escalante, N. G. Abraham, J. C. McGiff, R. D. Levere, and M. L. Schwartzman. 1989. Treatment with tin prevents the development of hypertension in spontaneously hypertensive rats. Science (Wash. DC). 243:388-390.
17. +-ATPase. Biochem. Biophys. Res. Commun. 152:1269-1273.
18. Escalante, B., W. C. Sessa, J. R. Falck, P. Yadagiri, and M. Laniado Schwartzman. 1989. Vasoactivity of 20-hydroxyeicosatetraenoic acid is dependent on metabolism by cyclooxygenase. J. Pharmacol. Exp. Ther. 248:229-232.
19. Lowry, O. H., N. J. Rosenbrough, A. L. Farr, and R. J. Randall. 1951. Protein measurement with the Folin phenol reagent. J. Biol. Chem. 193:265-275.
20. Omura, T., and R. Sato. 1964. The carbon monoxide-binding pigment of liver microsomes. J. Biol. Chem. 239:2370-2378.
21. Tenhunen, R., H. S. Marver, and R. Schmid. 1970. The enzymatic catabolism of hemoglobin: stimulation of microsomal heme oxygenase by hemin. J. Lab. Clin. Med. 75:410-421.
22. Abraham, N. G., J. D. Lutton, M. L. Freedman, and R. D. Levere. 1986. Benzene modulation of liver cell structure and hemecytochrome P450 metabolism. Am. J. Med. Sci. 292:81-86.
23. Shibahara, S., R. Muller, H. Taguchi, and T. Yoshida. 1985. Cloning and expression of cDNA for rat heme oxygenase. Proc. Natl. Acad. Sci. USA. 82:7865-7869.
24. Shibahara, S., R. Muller, and H. Taguchi. 1987. Transcriptional control of rat heme oxygenase by heat shock. J. Biol. Chem. 262:12889-12892.
25. Abraham, N. G., J. H-C. Lin, S. M. Mitrione, M. L. Schwartzman, R. D. Levere, and S. Shibahara. 1988. Biochem. Biophys. Res. Commun. 150:717-722.
26. Feinberg, A. P., and B. Vogelstein. 1983. A technique for radiolabeling DNA restriction endonuclease fragments to high specific activity. Anal. Biochem. 132:6-13.
27. Martasek, P., K. Solangi, A. I. Goodman, R. D. Levere, R. J. Chernick, and N. G. Abraham. 1988. Properties of human kidney heme oxygenase: inhibition by synthetic heme analogues and metalloporphyrins. Biochem. Biophys. Res. Commun. 157:480-487.
28. Schwartzman, M. L., N. G. Abraham, M. A. Carroll, R. D. Levere, and J. C. McGiff. 1986. Regulation of arachidonic acid metabolism by cytochrome P450 in rabbit kidney. Biochem. J. 238:283-240.
29. Abraham, N. G., J. H-C. Lin, M. L. Schwartzman, R. D. Levere, and S. Shibahara. 1988. The physiological significance of heme oxygenase. Int. J. Biochem. 20:543-558.
30. Ignarro, L. J. 1989. Endothelium-derived nitric oxide: actions and properties. FASEB (Fed. Am. Soc. Exp. Biol.) J. 3:31-36.
31. Rees, D. D., M. J. Palmer, and S. Moncada. 1989. Role of endotheiium-derived nitric oxide in the regulation of blood pressure. Proc. Natl. Acad. Sci. USA. 86:3375-3378.
32. G-methylarginine, an inhibitor of endotheiium-derived nitric oxide synthesis, is a potent pressor agent in the guinea pig: does nitric oxide regulate blood pressure in vivo? Biochem. Biophys. Res. Commun. 160:881-886.